Actively Recruiting
Effetivity of Dutasteride and Aloe Vera Extract Combination on Angiogenesis and Obstruction on Benign Prostatic Hyperplasia
Led by Universitas Diponegoro · Updated on 2025-07-15
84
Participants Needed
1
Research Sites
230 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is a double blinded RCT with pre-post test design on the effect of combination of dutasteride and aloe vera, compared to dutasteride only, on uroflowmetry results, prostate volume, and VEGF serum level among patients with benign prostate hyperplasia. The treatment was given for 12 weeks
CONDITIONS
Official Title
Effetivity of Dutasteride and Aloe Vera Extract Combination on Angiogenesis and Obstruction on Benign Prostatic Hyperplasia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with BPH clinically or radiologically (prostate volume > 30 gram, Qmax <15 mL/s)
- Willing to participate to the study
You will not qualify if you...
- Clinically or radiologically suspected of having prostatic cancer
- Previous prostatic surgery
- Patients with urinary retention
- Patients with BPH complications: urinary tract infections, urolithiasis, or hydronephrosis
- Previously consumed alpha blocker or 5ARI in the last 6 months
- Have consumed aloe vera extract routinely
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
RSUD Karawang
Karawang, West Java, Indonesia
Actively Recruiting
Research Team
A
Achmad Rizky Herda Pratama dr. Achmad Rizky Herda Pratama, Sp.U, S.H, Urologist
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here